CY1125541T1 - Ακλινιδιο για χρηση για την αυξηση της σωματικης δραστηριοτητας στην καθημερινη ζωη σε ασθενη που πασχει απο χρονια αποφρακτικη πνευμονοπαθεια - Google Patents
Ακλινιδιο για χρηση για την αυξηση της σωματικης δραστηριοτητας στην καθημερινη ζωη σε ασθενη που πασχει απο χρονια αποφρακτικη πνευμονοπαθειαInfo
- Publication number
- CY1125541T1 CY1125541T1 CY20221100578T CY221100578T CY1125541T1 CY 1125541 T1 CY1125541 T1 CY 1125541T1 CY 20221100578 T CY20221100578 T CY 20221100578T CY 221100578 T CY221100578 T CY 221100578T CY 1125541 T1 CY1125541 T1 CY 1125541T1
- Authority
- CY
- Cyprus
- Prior art keywords
- daily life
- physical activity
- aclinidium
- patient
- pulmonary disease
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12382507 | 2012-12-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1125541T1 true CY1125541T1 (el) | 2026-02-25 |
Family
ID=47458806
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20221100578T CY1125541T1 (el) | 2012-12-17 | 2022-08-29 | Ακλινιδιο για χρηση για την αυξηση της σωματικης δραστηριοτητας στην καθημερινη ζωη σε ασθενη που πασχει απο χρονια αποφρακτικη πνευμονοπαθεια |
Country Status (23)
| Country | Link |
|---|---|
| US (3) | US20150328194A1 (https=) |
| EP (1) | EP2931275B1 (https=) |
| JP (1) | JP6346618B2 (https=) |
| KR (1) | KR20150096400A (https=) |
| CN (1) | CN104869996A (https=) |
| AR (1) | AR094063A1 (https=) |
| AU (1) | AU2013363837A1 (https=) |
| CA (1) | CA2892928A1 (https=) |
| CY (1) | CY1125541T1 (https=) |
| DK (1) | DK2931275T3 (https=) |
| ES (1) | ES2917879T3 (https=) |
| HR (1) | HRP20221034T1 (https=) |
| HU (1) | HUE059569T2 (https=) |
| IL (1) | IL239245A0 (https=) |
| LT (1) | LT2931275T (https=) |
| PL (1) | PL2931275T3 (https=) |
| PT (1) | PT2931275T (https=) |
| RS (1) | RS63476B1 (https=) |
| SI (1) | SI2931275T1 (https=) |
| SM (1) | SMT202200303T1 (https=) |
| TW (1) | TW201427660A (https=) |
| UY (1) | UY35196A (https=) |
| WO (1) | WO2014095663A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2165768B1 (es) | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen. |
| EP2100599A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
| EP2510928A1 (en) | 2011-04-15 | 2012-10-17 | Almirall, S.A. | Aclidinium for use in improving the quality of sleep in respiratory patients |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT837710E (pt) | 1995-06-21 | 2002-05-31 | Sofotec Gmbh & Co Kg | Cartucho de po farmaceutico com dispositivo de doseamento integrado e inalador para medicamentos em po |
| ES2165768B1 (es) | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen. |
| DE10129703A1 (de) | 2001-06-22 | 2003-01-02 | Sofotec Gmbh & Co Kg | Zerstäubungssystem für eine Pulvermischung und Verfahren für Trockenpulverinhalatoren |
| ES2195785B1 (es) | 2002-05-16 | 2005-03-16 | Almirall Prodesfarma, S.A. | Nuevos derivados de piridazin-3(2h)-ona. |
| ES2211344B1 (es) | 2002-12-26 | 2005-10-01 | Almirall Prodesfarma, S.A. | Nuevos derivados de piridazin-3(2h)-ona. |
| ES2232306B1 (es) | 2003-11-10 | 2006-08-01 | Almirall Prodesfarma, S.A. | Nuevos derivados de piridazin-3(2h)-ona. |
| ES2251866B1 (es) | 2004-06-18 | 2007-06-16 | Laboratorios Almirall S.A. | Nuevos derivados de piridazin-3(2h)-ona. |
| ES2251867B1 (es) | 2004-06-21 | 2007-06-16 | Laboratorios Almirall S.A. | Nuevos derivados de piridazin-3(2h)-ona. |
| PT1616592E (pt) | 2004-07-16 | 2010-12-10 | Almirall Sa | Inalador para administração de fármacos em pó e um cartucho de pó para utilização com este inalador |
| EP2100598A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
| EP2100599A1 (en) * | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
| EP2196465A1 (en) | 2008-12-15 | 2010-06-16 | Almirall, S.A. | (3-oxo)pyridazin-4-ylurea derivatives as PDE4 inhibitors |
-
2013
- 2013-12-13 LT LTEPPCT/EP2013/076606T patent/LT2931275T/lt unknown
- 2013-12-13 CN CN201380066242.4A patent/CN104869996A/zh active Pending
- 2013-12-13 SI SI201331994T patent/SI2931275T1/sl unknown
- 2013-12-13 US US14/652,817 patent/US20150328194A1/en not_active Abandoned
- 2013-12-13 AU AU2013363837A patent/AU2013363837A1/en not_active Abandoned
- 2013-12-13 DK DK13805376.4T patent/DK2931275T3/da active
- 2013-12-13 ES ES13805376T patent/ES2917879T3/es active Active
- 2013-12-13 EP EP13805376.4A patent/EP2931275B1/en active Active
- 2013-12-13 PT PT138053764T patent/PT2931275T/pt unknown
- 2013-12-13 WO PCT/EP2013/076606 patent/WO2014095663A1/en not_active Ceased
- 2013-12-13 RS RS20220736A patent/RS63476B1/sr unknown
- 2013-12-13 PL PL13805376.4T patent/PL2931275T3/pl unknown
- 2013-12-13 HU HUE13805376A patent/HUE059569T2/hu unknown
- 2013-12-13 JP JP2015547055A patent/JP6346618B2/ja active Active
- 2013-12-13 KR KR1020157015515A patent/KR20150096400A/ko not_active Withdrawn
- 2013-12-13 HR HRP20221034TT patent/HRP20221034T1/hr unknown
- 2013-12-13 CA CA2892928A patent/CA2892928A1/en not_active Abandoned
- 2013-12-13 SM SM20220303T patent/SMT202200303T1/it unknown
- 2013-12-17 AR ARP130104797A patent/AR094063A1/es unknown
- 2013-12-17 TW TW102146516A patent/TW201427660A/zh unknown
- 2013-12-17 UY UY0001035196A patent/UY35196A/es not_active Application Discontinuation
-
2015
- 2015-06-04 IL IL239245A patent/IL239245A0/en unknown
-
2016
- 2016-07-25 US US15/218,391 patent/US20160331733A1/en not_active Abandoned
-
2017
- 2017-02-17 US US15/436,178 patent/US20180000798A1/en not_active Abandoned
-
2022
- 2022-08-29 CY CY20221100578T patent/CY1125541T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK2931275T3 (da) | 2022-07-04 |
| US20180000798A1 (en) | 2018-01-04 |
| IL239245A0 (en) | 2015-07-30 |
| JP2016502992A (ja) | 2016-02-01 |
| AR094063A1 (es) | 2015-07-08 |
| CA2892928A1 (en) | 2014-06-26 |
| US20160331733A1 (en) | 2016-11-17 |
| ES2917879T3 (es) | 2022-07-12 |
| SI2931275T1 (sl) | 2022-07-29 |
| JP6346618B2 (ja) | 2018-06-20 |
| KR20150096400A (ko) | 2015-08-24 |
| UY35196A (es) | 2014-07-31 |
| LT2931275T (lt) | 2022-06-27 |
| HRP20221034T1 (hr) | 2022-11-11 |
| HUE059569T2 (hu) | 2022-11-28 |
| WO2014095663A1 (en) | 2014-06-26 |
| AU2013363837A1 (en) | 2015-06-11 |
| SMT202200303T1 (it) | 2022-09-14 |
| PL2931275T3 (pl) | 2022-09-05 |
| RS63476B1 (sr) | 2022-08-31 |
| US20150328194A1 (en) | 2015-11-19 |
| EP2931275A1 (en) | 2015-10-21 |
| CN104869996A (zh) | 2015-08-26 |
| TW201427660A (zh) | 2014-07-16 |
| PT2931275T (pt) | 2022-06-30 |
| EP2931275B1 (en) | 2022-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1120334T1 (el) | Υποκατεστημενης 3-αλλογονοαλυλαμινης αναστολεις ssao και χρησεις αυτων | |
| CY1120939T1 (el) | Συνδυασμος ρεγοραφενιμπης και ακετυλοσαλικυλικου οξεος για τη θεραπευτικη αντιμετωπιση του ορθοκολικου καρκινου | |
| CY1119058T1 (el) | Ενωσεις ιμιδαζοπυρρολιδινονης | |
| CY1121150T1 (el) | Νευροδραστικα 19-αλκοξυ-17-υποκατεστημενα στεροειδη, χρησιμα σε μεθοδους θεραπειας | |
| CY1125541T1 (el) | Ακλινιδιο για χρηση για την αυξηση της σωματικης δραστηριοτητας στην καθημερινη ζωη σε ασθενη που πασχει απο χρονια αποφρακτικη πνευμονοπαθεια | |
| CY1118839T1 (el) | Επικαλυμμενη φαρμακευτικη συνθεση που περιεχει ρεγοραφενιμπη | |
| EA201490419A1 (ru) | Соединения для лечения и профилактики респираторного синцитиального вирусного заболевания | |
| MX356728B (es) | Combinación farmacéutica para usar en el tratamiento de pacientes que padecen diabetes de tipo 2. | |
| TWD161529S (zh) | 治療燈 | |
| PH12014501997A1 (en) | Esketamine for the treatment of treatment-refractory or treatment-resistant depression | |
| CR20130043A (es) | Compuestos terapéuticos | |
| CY1120094T1 (el) | Φαρμακευτικη συνθεση που περιλαμβανει despr036 eξenδinh-4(1-39)-lys6-nh2 για χρηση στην θεραπευτικη αγωγη μιας νευροεκφυλιστικης ασθενειας | |
| IL233313A0 (en) | Composition of novel carbohydrate drug for treatment of human diseases | |
| NZ704266A (en) | Inhibitors of alpha-crystallin aggregation for the treatment for cataract | |
| CY1119725T1 (el) | Ημιστερεη υδατικη φαρμακευτικη συνθεση που περιεχει ταπενταδολη | |
| HUE053409T2 (hu) | Ortopédiai szék a gerincbetegségek kezelésére és megelõzésére | |
| EA201590359A1 (ru) | Лечение ревматоидного артрита | |
| CY1117426T1 (el) | Παρεντερικη χορηγηση ταπενταδολης | |
| CY1118786T1 (el) | Ακλιδινιο για χρηση στη βελτιωση της ποιοτητας του υπνου σε ασθενεις με αναπνευστικες παθησεις | |
| CO6561789A2 (es) | Método de tratamiento | |
| EA201400623A1 (ru) | Новые 2h-индазолы в качестве антагонистов рецептора ep | |
| CY1118287T1 (el) | Χρηση αλατων βολφραμιου (vi) για την θεραπεια γυναικειας ελλειψης γονιμοτητας σε μη-διαβητικα θηλαστικα | |
| CY1122418T1 (el) | Αγωγη ερυθρομελαλγιας | |
| CY1118645T1 (el) | Χρηση pidotimod στη θεραπεια της ψωριασης | |
| EA201490233A8 (ru) | Стабильные лекарственные формы артеролана и пиперахина |